Ravi Salgia to Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
This is a "connection" page, showing publications Ravi Salgia has written about Precursor B-Cell Lymphoblastic Leukemia-Lymphoma.
Connection Strength
0.251
-
A selective small molecule c-MET Inhibitor, PHA665752, cooperates with rapamycin. Clin Cancer Res. 2005 Mar 15; 11(6):2312-9.
Score: 0.251
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.